BioSpace News Archive

Step Pharma, a biotech company developing novel drugs for oncology and autoimmune diseases, announced the appointment of Dr. Adrian Senderowicz to its Board of Directors.

ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, announced preliminary, unaudited sales results for the third quarter ended September 30, 2021.

Rafael Holdings, Inc., a pharmaceutical holding company focused on developing novel cancer metabolism therapeutics through its Barer Institute and investment in Rafael Pharmaceuticals, Inc., announced the appointment of Mary Margaret Huizinga, MD, MPH as Chief Development and Medical Officer, effective October 18, 2021.

Bright Minds Biosciences today announced that Ian McDonald, Chief Executive Officer of Bright Minds, will present at the LD Micro Main Event Small Cap Investment Conference as follows: Date: Tuesday, October 12, 2021

BD, a leading global medical technology company, announced it has received 510 clearance for expanded indications from the U.S. Food and Drug Administration for the Rotarex™ Atherectomy System.

Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, announced Hirosaki University Hospital has entered into an agreement to lease and utilize a Senhance® Surgical System.

Recro Pharma, Inc. today announced the expansion of its team through the addition of new employees to support product development, business development, quality, technical operations

Landos Biopharma, Inc. today announced the publication of a peer-reviewed article titled “First-in-class topical therapeutic omilancor ameliorates disease severity and inflammation through activation of the LANCL2 pathway in psoriasis” in Scientific Reports.

Voyager receives $30 million up front with potential option exercise fees and milestone payments of up to $600 million plus product sales-based royalties

Microbot Medical Inc. (Nasdaq: MBOT), announced that the United States Patent and Trade Office (USPTO) has issued a Notice of Allowance covering the Company’s LIBERTY® Robotic System.